BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12953287)

  • 1. General linear contrasts on latent variable means: structural equation hypothesis tests for multivariate clinical trials.
    Donaldson GW
    Stat Med; 2003 Sep; 22(18):2893-917. PubMed ID: 12953287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural equation modelling approach to the analysis of change.
    Tu YK; Baelum V; Gilthorpe MS
    Eur J Oral Sci; 2008 Aug; 116(4):291-6. PubMed ID: 18705795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis testing in functional linear regression models with Neyman's truncation and wavelet thresholding for longitudinal data.
    Yang X; Nie K
    Stat Med; 2008 Mar; 27(6):845-63. PubMed ID: 17610294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches.
    Vickers AJ
    Psychosom Med; 2005; 67(4):652-5. PubMed ID: 16046383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part I: structural nested models and marginal structural models to test and estimate treatment arm effects.
    Yamaguchi T; Ohashi Y
    Stat Med; 2004 Jul; 23(13):1991-2003. PubMed ID: 15211598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing bivariate repeated measures for discrete and continuous outcome variables.
    Rochon J
    Biometrics; 1996 Jun; 52(2):740-50. PubMed ID: 8672710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to adjust for multivariate confounders in small randomized studies applied to dendritic cell vaccination data.
    Wittkowski KM
    Stud Health Technol Inform; 2000; 77():321-4. PubMed ID: 11187565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian methods for latent trait modelling of longitudinal data.
    Dunson DB
    Stat Methods Med Res; 2007 Oct; 16(5):399-415. PubMed ID: 17656454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A latent change score analysis of a randomized clinical trial in reasoning training.
    McArdle JJ; Prindle JJ
    Psychol Aging; 2008 Dec; 23(4):702-19. PubMed ID: 19140642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysing sequential events in clinical trials.
    Salter A; Raab G; Day S
    Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An introduction to latent growth curve modelling for longitudinal continuous data in dental research.
    Tu YK; D'Aiuto F; Baelum V; Gilthorpe MS
    Eur J Oral Sci; 2009 Aug; 117(4):343-50. PubMed ID: 19627343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-outcome design for randomized comparative phase II clinical trials.
    Hong S; Wang Y
    Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitivity analysis for shared-parameter models for incomplete longitudinal outcomes.
    Creemers A; Hens N; Aerts M; Molenberghs G; Verbeke G; Kenward MG
    Biom J; 2010 Feb; 52(1):111-25. PubMed ID: 19937996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.